U.S. STOCKS ON THE MOVE-Nike, Perrigo, Altria, CalAmp

The Day Ahead newsletter:

The Morning News Call newsletter:

Wall Street was mixed in volatile trading on Friday after two days of heavy losses, as concerns of slowing global growth and the threat of a U.S. government shutdown weighed on investors' minds.

The top three S&P 500 percentage gainers:

** Nike Inc , up 8.2 pct

** Carmax Inc , up 2.2 pct

** Foot Locker Inc , up 3.9 pct

The top S&P 500 percentage losers:

** Perrigo Co Plc, down 21.7 pct

** Conagra Brands Inc , down 2.9 pct

The top three NYSE percentage gainers:

** Sunlands Online Education Group, up 17.3 pct

** Companhia Energetica de Minas Gerais , up 4.3 pct

** Castlight Health Inc , up 6.6 pct

The top three NYSE percentage losers:

** Perrigo Co Plc, down 21.7 pct

** Invesco S&P SmallCap Quality ETF , down 20.5 pct

** Cambria Foreign Shareholder Yield ETF , down 13.4 pct

The top three Nasdaq percentage gainers:

** Obalon Therapeutics Inc , up 45.1 pct

** NF Energy Saving Corp , up 20.3 pct

** BioHiTech Global Inc, up 20.5 pct

The top three Nasdaq percentage losers:

** Wheeler Real Estate Investment Trust Inc , down 52.7 pct

** Wheeler Real Estate Investment Trust Inc , down 49.4 pct

** Piedmont Lithium Ltd, down 20 pct

** Obalon Therapeutics Inc: up 45.1 pct

Surges on FDA approval of imaging technology

** Nike Inc: up 8.2 pct

Shares rally after Q2 results beat on strong N.America online sales

** Walgreens Boots Alliance Inc: down 1.2 pct

Street View: Int'l, wholesale businesses continue to be a drag on Walgreens

** Perrigo Company Plc: down 21.7 pct

Falls after $1.9 bln tax bill from Ireland authorities

** Accenture Plc: down 1.0 pct

Street View: Accenture's "solid" qtr overshadowed by weak forecast

** Altria Group Inc: down 2.0 pct

Gets first 'sell' ratings in over a year on "rich" Juul deal

** KKR & Co Inc: up 1.3 pct

Telepizza gains 30 pct in two days on KKR takeover bid

** Proteostasis Therapeutics Inc: down 3.0 pct

Falls as co delays reporting cystic fibrosis trial data

** TRACON Pharmaceuticals Inc: down 27.7 pct

Tumbles after cancer drug fails mid-stage trial

** CalAmp Corp: down 12.5 pct

CalAmp Corp: Analysts cut PT on supply chain, macro concerns

The 11 major S&P 500 sectors:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.